Tactile Systems Technology Inc
NASDAQ:TCMD
Tactile Systems Technology Inc
Cash from Operating Activities
Tactile Systems Technology Inc
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Tactile Systems Technology Inc
NASDAQ:TCMD
|
Cash from Operating Activities
$40.7m
|
CAGR 3-Years
149%
|
CAGR 5-Years
75%
|
CAGR 10-Years
N/A
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Operating Activities
$3.7B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
8%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Operating Activities
$2.9B
|
CAGR 3-Years
16%
|
CAGR 5-Years
10%
|
CAGR 10-Years
9%
|
|
|
Stryker Corp
NYSE:SYK
|
Cash from Operating Activities
$4.2B
|
CAGR 3-Years
9%
|
CAGR 5-Years
14%
|
CAGR 10-Years
9%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Operating Activities
$8.6B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
7%
|
CAGR 10-Years
9%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Operating Activities
$1.8B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
11%
|
|
Tactile Systems Technology Inc
Glance View
Tactile Systems Technology, Inc. is a medical technology company. The company is headquartered in Minneapolis, Minnesota and currently employs 988 full-time employees. The company went IPO on 2016-07-28. Its therapeutic focus is vascular disease, for treating lymphedema and chronic venous insufficiency. The company is a manufacturer and distributor of the Flexitouch and Entre systems, medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition. Its at-home Flexitouch system provides automated, at-home lymphatic drainage therapy. Its Flexitouch Plus system is an automated, programmable, pneumatic compression device (APCD), designed for the treatment of lymphedema in the home setting. Its Entre system is a pneumatic compression device used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company possesses a platform to deliver at-home healthcare solutions directly to patients throughout the United States.
See Also
What is Tactile Systems Technology Inc's Cash from Operating Activities?
Cash from Operating Activities
40.7m
USD
Based on the financial report for Dec 31, 2024, Tactile Systems Technology Inc's Cash from Operating Activities amounts to 40.7m USD.
What is Tactile Systems Technology Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
75%
Over the last year, the Cash from Operating Activities growth was 13%. The average annual Cash from Operating Activities growth rates for Tactile Systems Technology Inc have been 149% over the past three years , 75% over the past five years .
You don't have any saved screeners yet